Arcellx, Inc. (ACLX)
63.62
-1.51
(-2.32%)
USD |
NASDAQ |
Dec 30, 16:00
63.31
-0.31
(-0.49%)
After-Hours: 20:00
Arcellx Market Cap: 3.679B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 152.84B |
| Johnson & Johnson | 498.58B |
| Amicus Therapeutics, Inc. | 4.395B |
| Relmada Therapeutics, Inc. | 331.83M |
| Invivyd, Inc. | 565.32M |
Market Cap Related Metrics
| PS Ratio | 98.52 |
| PEG Ratio | -0.0382 |
| Price to Book Value | 8.346 |
| Price | 63.62 |
| Earnings Yield | -6.16% |
| PEGY Ratio | -0.0382 |